MedPath

Study of Bioactive Glass-ceramic Intervertebral Spacer (Bonglass-SS) in Posterior Lumbar Interbody Fusion

Not Applicable
Conditions
Degenerative Disk Disease
Registration Number
NCT01439464
Lead Sponsor
BioAlpha Inc.
Brief Summary

The goal of this study is to compare Bonglass-SS with titanum cage.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
86
Inclusion Criteria
  • 30~80 aged patients needed single-level posterior Interbody fusion at L1~S1
  • A subject who provided written informed consent to participate in this study
Exclusion Criteria
  • Patitents with BMD T-score < -3.0
  • Women who are pregnant or plan to be pregnant within 3 years
  • Patient with malignant tumor

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Radiographic assessments of fusion and instability at 12 months after surgery12 months
Secondary Outcome Measures
NameTimeMethod
CT assessments of fusion at 12 months after surgery12 months

Trial Locations

Locations (4)

Dongguk University Medical Center

🇰🇷

Goyang-si, Gyeonggi-do, Korea, Republic of

Seoul National University Bundang Hospital

🇰🇷

Sungnam-Si, Gyeonggi-Do, Korea, Republic of

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

Seoul National University Seoul Metropolitan Boramae Medical Center

🇰🇷

Seoul, Korea, Republic of

Dongguk University Medical Center
🇰🇷Goyang-si, Gyeonggi-do, Korea, Republic of
KiHyoung Koo, M.D.,Ph.D.
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.